From the Editors

  • Copyright
    © 2022 PRO MEDICINA Foundation, Published by PRO MEDICINA Foundation
    User License
    The journal provides published content under the terms of the Creative Commons 4.0 Attribution-International Non-Commercial Use (CC BY-NC 4.0) license.


Name Affiliation
Karina Jahnz-Różyk
Military Institute of Medicine, Warsaw, Poland
contributed: 2022-06-29
final review: 2022-06-29
published: 2022-06-29
Corresponding author:


Dear Readers, 

The first issue of JHPOR in 2022 consists of several articles devoted to various topics of public health and pharmacoeconomics.

We especially encourage you to read the following articles:

·       The use of a systematic review to verify the completeness of the PharmGKB database based on the search for genetic variant related side effects during ovarian cancer treatment with platinum compounds

·       SGLT2 inhibitors and cardioprotection. Literature review and real-world data from Poland

We are aware of a certain reduction in editorial activity due to the current geopolitical situation as well as the earlier Covid-19 pandemic. We hope that this situation will change soon, which will have an impact on the authors' activity.

We wish you an interesting reading while waiting for the next publications.

Karina Jahnz-Różyk, Editor-in-Chief

Monika Szkultecka-Dębek, Deputy Editor-in-Chief

Joanna Lis, Deputy Editor-in-Chief

About Us

Journal of Health Policy & Outcomes Research (JHPOR) is a peer-reviewed, international scientific journal, covering health policy, pharmacoeconomics and outcomes research in Poland and worldwide. The journal is issued under the auspices of the Polish Society of Pharmacoeconomics.

Subscribe to our newsletter:

Latest Articles

Our Contacts

Śliska 3 lok. 55
00-127 Warszawa
NIP 5252390463
REGON 140936540
KRS 0000277843

2017 © Pro Medicina Foundation